Cost-effectiveness analysis of selexipag for the combined treatment of pulmonary arterial hypertension

Overview of attention for article published in Frontiers in Pharmacology, August 2023

Altmetric Badge

Mentioned by

twitter: 1 X user

Readers on

mendeley: 5 Mendeley

So far, Altmetric has seen 1 X post from an account with 5,881 followers.

New Research: Cost-effectiveness analysis of selexipag for the combined treatment of pulmonary arterial hypertension #pharmacology https://t.co/7Hy3iMyftc

11 Aug 2023

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.